Want to see PRME full AI Analyst Report?
Prime Medicine, Inc. (PRME) Ownership - Who Owns Prime Medicine, Inc.?
Prime Medicine, Inc. (PRME) Ownership Overview
- 13.25% Insiders
- 7.47% Mutual Funds
- 2.49% Other Institutional Investors
- 14.22% ETFs
- 62.56% Public Companies and Individual Investors
The ownership structure of Prime Medicine, Inc. (PRME) stock is a mix of institutional, retail, and individual investors. Approximately 24.18% of the company’s stock is owned by Institutional Investors, 13.25% is owned by Insiders, and 62.56% is owned by Public Companies and Individual Investors.
The ownership structure of Prime Medicine, Inc. (PRME) stock is a mix of institutional, retail, and individual investors. Approximately 9.97% of the company’s stock is owned by Institutional Investors, 13.25% is owned by Insiders, and 14.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Ark Investment Management Llc | $30,806,873 | |
| Jun 30, 2026 | Woodline Partners Lp | $11,084,406 | |
| Jun 30, 2026 | Graham Capital Management, L.p. | $68,324 | |
| Jun 30, 2026 | $35,431,531 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Robert Nelsen | 18,502,974 | Insider | 10.20% | 87,334,037 |
| Ark | 8,550,595 | Institution | 4.71% | 40,358,808 |
| Cathie Wood | 8,348,746 | Institution | 4.60% | 39,406,081 |
| Vanguard | 5,454,256 | Institution | 3.01% | 25,744,088 |
| Thomas Cahill | 5,305,679 | Insider | 2.93% | 25,042,805 |
| Ishares | 4,918,088 | Institution | 2.71% | 23,213,375 |
| Vanguard Index Funds | 4,420,823 | Institution | 2.44% | 20,866,285 |
| Spdr | 4,218,505 | Institution | 2.33% | 19,911,344 |
| Michael Rockefeller | 3,003,904 | Institution | 1.66% | 14,178,427 |
| T. Rowe Price Small-cap Value Fund, Inc. | 1,357,362 | Institution | 0.75% | 6,406,749 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 4,420,823 | Institution | 2.44% | 20,866,285 |
| T. Rowe Price Small-cap Value Fund, Inc. | 1,357,362 | Institution | 0.75% | 6,406,749 |
| T. Rowe Price Small-cap Stock Fund, Inc. | 1,219,872 | Institution | 0.67% | 5,757,796 |
| Fidelity Salem Street Trust | 1,134,917 | Institution | 0.63% | 5,356,808 |
| Fidelity Concord Street Trust | 1,083,078 | Institution | 0.60% | 5,112,128 |
| T. Rowe Price Equity Funds, Inc. | 783,011 | Institution | 0.43% | 3,695,812 |
| Blackrock Funds | 715,981 | Institution | 0.39% | 3,379,430 |
| Vanguard Scottsdale Funds | 649,341 | Institution | 0.36% | 3,064,890 |
| Tiaa-cref Funds | 330,609 | Institution | 0.18% | 1,560,474 |
| Schwab Capital Trust | 317,114 | Institution | 0.17% | 1,496,778 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| ARK | 8,006,915 | Institution | 4.41% | 37,792,639 |
| SPDR | 3,780,964 | Institution | 2.08% | 19,812,251 |
| Vanguard | 3,120,450 | Institution | 1.72% | 9,532,975 |
| iShares | 2,380,487 | Institution | 1.31% | 12,473,752 |
| Vanguard | 1,356,820 | Institution | 0.75% | 4,145,085 |
| iShares | 776,512 | Institution | 0.43% | 3,665,137 |
| iShares | 740,822 | Institution | 0.41% | 3,496,680 |
| Selectra Investments | 670,000 | Institution | 0.37% | 1,801,963 |
| Schwab | 630,684 | Institution | 0.35% | 3,304,784 |
| Vanguard | 547,947 | Institution | 0.30% | 1,673,978 |
FAQ
Who Owns Prime Medicine, Inc. (PRME)?
According to the latest TipRanks data, approximately 2.49% of the company's stock is held by institutional investors, 13.25% is held by insiders, and 62.56% is held by retail investors.
What percentage of Prime Medicine, Inc. (PRME) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.49% of Prime Medicine, Inc. (PRME) stock is held by institutional investors.
What percentage of Prime Medicine, Inc. (PRME) stock is held by retail investors?
According to the latest TipRanks data, approximately 62.56% of Prime Medicine, Inc. (PRME) stock is held by retail investors.
Who owns the most shares of Prime Medicine, Inc. (PRME)?
Robert Nelsen owns the most shares of Prime Medicine, Inc. (PRME).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.